Overview

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Status:
Recruiting

Trial end date:
2025-02-01

Target enrollment:

Participant gender:

Summary

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Phase:

Phase 3

Details

Lead Sponsor:

Clarity Pharmaceuticals Ltd